FilingReader Intelligence
Zhongsheng Pharma signs agreement for raised funds supervision
June 27, 2025 at 11:17 AM UTC•By FilingReader AI
Guangdong Zhongsheng Pharmaceutical (SZSE:002317) announced the signing of a tripartite supervision agreement to manage and secure raised funds following a shift in allocation plans approved earlier in June 2025. The agreement involves the company, its subsidiary Guangdong Zhongsheng Ruichuang Biotechnology, the deposit bank, and the underwriter, Huatai United Securities.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SZSE:002317•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Guangdong Zhongsheng Pharmaceutical publishes news
Free account required • Unsubscribe anytime